Evidence map

ArticleOncoimmunology2025

Immuno-oncological effects of the α2-adrenoceptor agonist dexmedetomidine.

Lucillia Bezu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40748168